Skip to content
FDA APPROVED bevacizumab (Lytenava) over a photo of an Amsler grid over a woman’s eye.

Branded Bevacizumab Approved for Wet AMD

The FDA approved the first formulation of bevacizumab specifically for the treatment of neovascular (wet) age-related macular degeneration (nAMD), Outlook Therapeutics announced on Friday. The approval of bevacizumab-vikg (Lytenava) follows… 

Orlando Bryant Mckee

Find the Perfect Health Insurance Plan for Your Needs

Compare health Insurance & supplemental plans from trusted insurance providers. Get personalized quotes in minutes and speak with a licensed agent today.

90% CHEAPER THAN COBRA

Compare plans from top insurers in under 3 minutes

Let’s get started!

Enter your ZIP code to see plans available in your area.

Must be 65+ for Medicare eligibility or turning 65 in the next 6 months